China launches a COVID-19 vaccine inhaled through the mouth


PTI, Oct 26, 2022, 2:01 PM IST

Representational Image by iStock

Beijing: The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Wednesday in what appears to be a world first.

The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated individuals, according to an announcement posted on an official city social media account.

Needle-free vaccines may persuade people who don’t like getting a shot to get vaccinated, as well as help expand vaccination in poor countries because they are easier to administer.

China doesn’t have vaccine mandates but wants more people to get booster shots before it relaxes strict pandemic restrictions that are holding back the economy and increasingly out of synch with the rest of the world.

A video posted by an online Chinese state media outlet showed people at a community health centre sticking the short nozzle of a translucent white cup into their mouths.

Accompanying text said that after slowly inhaling, one individual held his breath for five seconds, with the entire procedure completed in 20 seconds.

“It was like drinking a cup of milk tea,” one Shanghai resident said in the video. ”When I breathed it in, it tasted a bit sweet.” A vaccine taken in the mouth could also fend off the virus before it reaches the rest of the respiratory system, though that would depend in part on the size of the droplets, one expert said.

Larger droplets would train defenses in parts of the mouth and throat, while smaller ones would travel further into the body, said Dr. Vineeta Bal, an immunologist in India.

Chinese regulators approved the vaccine for use as a booster in September. It was developed by Chinese biopharmaceutical company Cansino Biologics Inc. as an aerosol version of the same company’s one-shot adenovirus vaccine, which uses a relatively harmless cold virus.

Cansino has said the inhaled vaccine has completed clinical trials in China, Hungary, Pakistan, Malaysia, Argentina and Mexico.

Regulators in India have approved a nasal vaccine, another needle-free approach, but it has yet to be rolled out. The vaccine, developed in the US and licensed to Indian vaccine maker Bharat Biotech, is squirted in the nose.

About a dozen nasal vaccines are being tested globally, according to the World Health Organisation.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Father and two sons drown in Ghataprabha river; search operations underway

Shinde defends rebellion, claims previous Shiv Sena leadership was anti-development

No urgent hearing on plea against appointment of Rashmi Shukla as DGP: HC

B’luru: Thief arrested for daylight robbery: Gold and cash worth Lakhs recovered

SC directs President’s secretary to place before her Beant assassination convict’s mercy plea

RSS remarks case: Lyricist Javed Akhtar acquitted as complainant withdraws case

VTU introduces 3.5-year ‘fast-track’ engineering degrees

Related Articles More

World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness

World Diabetes Day: An overview of types of diabetes

World Diabetes Day: One-fourth of people living with diabetes in 2022 are in India, Lancet study estimates

Disruption in liver-brain communication behind overeating, Study claims

Acute Blood Shortage at Kasturba Hospital, Manipal: Donate blood and save lives

MUST WATCH

Swimming pool

| ₹50 LAKH SEIZED FROM TIRE |

New Technology In Kambala

Lakshdeepotsava 2024 Shree Krishna Mutt

Punganur Cow


Latest Additions

Father and two sons drown in Ghataprabha river; search operations underway

Shinde defends rebellion, claims previous Shiv Sena leadership was anti-development

No urgent hearing on plea against appointment of Rashmi Shukla as DGP: HC

B’luru: Thief arrested for daylight robbery: Gold and cash worth Lakhs recovered

SC issues notice to Centre over vacancies in Debt Recovery Tribunals

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.